DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes.
Atish KizhakeyilNurmahirah Binte Mohammed ZainiZhi Sheng PohBrandon Han Siang WongXinpeng LohAik Seng NgZun Siong LowPraseetha PrasannanChun GongMichelle Guet Khim TanChandramouli NagarajanDachuan HuangPang Wan LuJing Quan LimSharon BarransChoon Kiat OngSoon Thye LimWee Joo ChngGeorge FollowsDaniel J HodsonMing Qing DuYeow Tee GohSuat Hoon TanNicholas Francis GrigoropoulosNavin Kumar VermaPublished in: Molecular cancer (2021)